Crossmark

IGF-1C domain-modified hydrogel enhances therapeutic potential of mesenchymal stem cells for hindlimb ischemia

Crossref DOI link: https://doi.org/10.1186/s13287-019-1230-0

Published Online: 2019-04-29

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhao, Nianhuan

Yue, Zhiwei

Cui, Jian

Yao, Yong

Song, Xianghe

Cui, Bangping

Qi, Xin

Han, Zhibo

Han, Zhong-Chao

Guo, Zhikun

He, Zuo-Xiang

Li, Zongjin https://orcid.org/0000-0002-4603-3743
Funding

Funding for this research was provided by:

National Key R&D Program of China (2017YFA0103200)

National Natural Science Foundation of China (81320108014)

National Natural Science Foundation of China (81671734)

Key Projects of Tianjin Science and Technology Support Program (18YFZCSY00010)

Natural Science Foundation of Tianjin Municipal Science and Technology Commission (16ZXMJSY00060)

Fundamental Research Funds for the Central Universities (63181114)
License Information

Text and Data Mining valid from 2019-04-29
More Information

Article History

Received: 30 October 2018

Revised: 3 March 2019

Accepted: 4 April 2019

First Online: 29 April 2019

Ethics approval and consent to participate

: The protocols involved animals, and the experimental procedures of the present study were approved by the Nankai University Animal Care and Use Committee guidelines that conform to the Guidelines for Animal Care approved by the National Institutes of Health (8th Edition, 2011).

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.